Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 819 of 6351
-
Promising new treatment for rare liver disease shows potential in Late-Stage trial
Disease control CompletedTo Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects with Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA). The primary objective is to evaluate the effect of seladelpar treat…
Phase 3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New combo therapy shows promise in brain cancer trial
Disease control CompletedThis is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients with newly diagnosed glioblastoma receiving concurrent radiation and temozolomide.
Phase 1/2 • Sponsor: Cantex Pharmaceuticals • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
A high-tech glove and nerve zaps may reawaken stroke-affected hands
Disease control CompletedHuman development as a species has been strongly associated with the ability to dexterously manipulate objects and tools. Unfortunately, current therapy efforts typically fail to restore fine manual control after stroke. The goal of this study is to evaluate a new intervention th…
Sponsor: North Carolina State University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Heart repair with stem cells: a new hope for chronic heart failure?
Disease control OngoingThe purpose of this clinical study is to evaluate the feasibility, safety and efficacy of intramyocardial injection of human induce pluripotent stem cell-derived cardiomyocytes (HiCM-188) during coronary artery bypass grafting (CABG) surgery in patients with severe chronic ischem…
Phase 1/2 • Sponsor: HELP Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New antibody drug targets Hard-to-Treat neuroendocrine cancers
Disease control Recruiting nowThis is a first-in-human, Phase 1/2, open-label, dose escalation, dose expansion and combination study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of Peluntamig (PT217) as a monotherapy and in combination with chemot…
Phase 1/2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could a simple blood test and PET scan replace painful bone marrow biopsies for myelofibrosis patients?
Diagnosis Recruiting nowChronic "Philadelphia-negative" myeloproliferative syndromes are chronic blood disorders. They include essential thrombocythemia, polycythemia vera, and myelofibrosis. Myelofibrosis may arise de novo ("primary myelofibrosis") or represent the evolution of essential thrombocythemi…
Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
New hope for lymphoma patients: trial pits novel drugs against standard chemo
Disease control Recruiting nowThe aim of the REFRACT clinical trial is to find new therapies with improved outcomes compared to the current standard treatment available, in patients with relapsed or refractory follicular lymphoma. This will be done by comparing patients who have received a new treatment again…
Phase 2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could simple changes prevent early stillbirth? new study investigates
Knowledge-focused Recruiting nowThis project aims to identify factors linked to pregnancy losses occurring between 20 and 28 weeks of pregnancy that can be modified by changing mother's behaviour or healthcare provision. The death of a child before birth (also called stillbirth or miscarriage) has enduring psy…
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Magic mushroom therapy slashes heavy drinking in new trial
Disease control CompletedNote: The trial is only eligible for citizens of Denmark. The purpose of this project is to assess the treatment efficacy of a single high dose of psilocybin administered within a protocol of psychological support to patients diagnosed with alcohol use disorder (AUD).
Phase 2 • Sponsor: Anders Fink-Jensen, MD, DMSci • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New chemo spray shows promise for Hard-to-Treat abdominal cancers
Disease control Recruiting nowPressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel minimally invasive drug delivery system for patients with peritoneal metastases (PM). It has been considered as a safe and feasible palliative treatment alternative proven by previous phase I studies. Currently a…
Phase 2 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Talk to your computer: could a chatbot detect Alzheimer's before you forget?
Diagnosis By invitation onlyEarly cognitive disorders diagnosis is becoming increasingly important due to population aging. The most common causes include Alzheimer's disease and frontotemporal dementia. These diseases are also manifested by changes in speech. NLP allows us to identify and classify these ch…
Sponsor: Faculty Hospital Kralovske Vinohrady • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
New hope for tough lymphomas: balstilimab trial opens
Disease control Recruiting nowThe goal of this study is to see if the drug balstilimab is safe and effective in participants with relapsed/refractory lymphomas. Participants will receive balstilimab every 3 weeks and their outcomes will be assessed periodically.
Phase 2 • Sponsor: Immune Oncology Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can specially crafted music soothe the anxious mind in Alzheimer's?
Symptom relief By invitation onlyClinically Designed Improvisatory Music (CDIM) is a form of improvised music based on calm-inducing sound parameters which brought relief to our cohort of neurology patients. As a direct sound-based approach, CDIM does not rely on autobiographical memory and may have wider applic…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New immune therapy aims to keep head and neck cancer at bay
Disease control Recruiting nowHead and neck cancer is the malignant tumor with the highest morbidity and mortality, of which 60% present with locally advanced disease at initial diagnosis, and the 5-year survival rate of standard treatment is less than 30%. Standard of care (SOC) including adjuvant and neoadj…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Modified immune cells aim to make stem cell transplants safer
Disease control Recruiting nowIn this clinical trial, the investigators aim to apply CD62L depleted donor lymphocyte infusion (DLI) together with in vitro T cell depleted haploidentical hematopoietic stem cell transplantation (HSCT) to treat patients with malignant or non-malignant disease in need of HSCT. Th…
Phase 2 • Sponsor: Hong Kong Children's Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:20 UTC
-
Two-Drug cocktail shows promise for awakening traumatic brain injury patients
Disease control CompletedThe goal of this interventional study is to Measure the potential benefits of combined administration of cerebrolysin and amantadine sulfate as an add-on therapy to the standard management of patients admitted to the ICU with traumatic brain injury.
Phase 3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug combo helps High-Risk kidney cancer patients avoid full kidney removal
Disease control CompletedThrough the neoadjuvant treatment with a combination of Cadonilimab and Lenvatinib, it enabled the successful and safe implementation of partial nephrectomy in patients with localized renal cancer, who had indications for nephron-sparing surgery but faced considerable difficulty …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a 1-Month pill course stop TB in schools?
Disease control Recruiting nowThis is a prospective, multi-center, open-label, cluster randomized controlled clinical trial conducted in school settings to estimate the non-inferiority effect of 1H3P3 compared with 3HR.
Phase 3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Personalized cell therapy takes on childhood cancers
Disease control Recruiting nowThis is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers.
Phase 1/2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Nerve block or talk therapy may prevent chronic pain in PTSD patients
Disease control Recruiting nowAlthough most people recover from acute pain (such as pain caused by injury, surgery, repetitive motion, or unknown causes), many people do not fully recover and will experience chronic pain. Untreated posttraumatic stress disorder (PTSD) appears to be a key risk factor for the t…
Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC